Prevention of Tumor Lysis Syndrome is critical, especially in high-risk patients. Preventative measures include:
Identifying high-risk patients before initiating therapy. Implementing appropriate hydration and possibly prophylactic medication (e.g., allopurinol or rasburicase). Gradual initiation of cytotoxic therapy to minimize rapid cell lysis. Frequent monitoring of electrolytes and renal function during treatment.
